a Modified NTU-HELP Program

October 4, 2017 updated by: National Taiwan University Hospital

Effect of the National Taiwan University Hospital Elder Life Program

The aim is to replicate, develop, and pilot test a model of care for the prevention and management of functional decline of older patients during hospitalization.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

to develop an intervention protocol that achieves clinical development objectives in a scientifically rigorous and time efficient manner.

Study Type

Interventional

Enrollment (Actual)

377

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 110
        • National Taiwan Unversity Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 65 year and older
  • Length of Stay is over 6 days
  • Able to communicate verbally or in writing

Exclusion Criteria:

  • Coma
  • Mechanism ventilation
  • Aphasia, if communication ability is severely impaired
  • Terminal condition with comfort care only, death imminent
  • Combative or dangerous behavior
  • Severe psychotic disorder that prevents patient from participating in interventions
  • Severe dementia (e.g. unable to communicate; MMSE=0). For patients with severe impairment (e.g. MMSE<10), decision to enroll will be made on a case-by-case basis depending on their ability to participate in intervention.
  • Respiratory isolation (e.g. tuberculosis). Patients on contact isolation (e.g. vancomycin-resistant enterococcus) or droplet precautions will be enrolled.
  • Discharge firmly anticipated within 6 days of admission. Enroll if discharge date unsure
  • Refusal by patient or family member.
  • Others. Reason to be well documented.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Care Group
Usual care consists of standard hospital services provided by physicians, nurses, and support staff (e.g., physical therapist, dietitian) in the general surgery units.
Experimental: Experimental Group
The intervention consisted of a daily inpatient care protocol on three core intervention protocols on top of hospital routine care.
The intervention consists of a daily inpatient care protocol on three core intervention protocols on top of hospital routine care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional status:Barthel Index.
Time Frame: through study completion, an average of 3 months
Changes from Baseline Barthel Index (BI) scores at 6 weeks after discharge
through study completion, an average of 3 months
Mini-Nutritional Assessment scores (MNA)
Time Frame: through study completion, an average of 3 months
Changes from Baseline Mini-Nutritional Assessment (MNA) scores at 6 weeks after discharge
through study completion, an average of 3 months
Mini Mental State Examination scores (MMSE)
Time Frame: through study completion, an average of 3 months
Changes from Baseline Mini Mental State Examination (MMSE) scores at 6 weeks after discharge
through study completion, an average of 3 months
Frailty rates and transition between frailty states
Time Frame: through study completion, an average of 3 months
Changes from Baseline Frailty rates at 6 weeks after discharge
through study completion, an average of 3 months
Postoperative delirium incidence rate [Confusion Assessment Method (CAM)]
Time Frame: through study completion, an average of 3 months
Record the incidence of postoperative delirium developing during hospitalization after surgery
through study completion, an average of 3 months
Postoperative bowel dysmotility
Time Frame: through study completion, an average of 3 months
Record the incidence of postoperative bowel dysmotility developing during hospitalization after surgery
through study completion, an average of 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body weight
Time Frame: through study completion, an average of 3 months
Changes from Baseline Body weight at 6 weeks after discharge
through study completion, an average of 3 months
Grip strength
Time Frame: through study completion, an average of 3 months
Changes from Baseline Grip strength at 6 weeks after discharge
through study completion, an average of 3 months
Oral health
Time Frame: through study completion, an average of 3 months
i.e., plaque index, screens of swallowing function
through study completion, an average of 3 months
Executive function
Time Frame: through study completion, an average of 3 months
ie.e, color trail test
through study completion, an average of 3 months
Geriatric Depressive Scale scores (GDS)
Time Frame: through study completion, an average of 3 months
Changes from Baseline Geriatric Depressive Scale scores (GDS) at 6 weeks after discharge
through study completion, an average of 3 months
Length of Hospital Stay (LOS)
Time Frame: through study completion, an average of 3 months
Record the length of hospital stay for abdominal surgery
through study completion, an average of 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cheryl Chai-Hui Chen, DNSc, National Taiwan University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2009

Primary Completion (Actual)

November 1, 2012

Study Completion (Actual)

November 1, 2012

Study Registration Dates

First Submitted

January 8, 2010

First Submitted That Met QC Criteria

January 8, 2010

First Posted (Estimate)

January 11, 2010

Study Record Updates

Last Update Posted (Actual)

October 6, 2017

Last Update Submitted That Met QC Criteria

October 4, 2017

Last Verified

May 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • 200803077R

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Early Ambulation

Clinical Trials on a modified NTU-HELP

Subscribe